Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ARSYNL Rx vs Invyncible

ARSYNL Rx
Graded #350

Lower grade

vs+1.8999999999999986
Invyncible
Graded #303

Higher grade

The verdict

Invyncible takes it — 61/100 to 59.1/100, but only just.

Invyncible grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management. ARSYNL Rx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvyncible +12
43
55
Dose & formulationEven
64
64
Clinical oversightARSYNL Rx +8
78
70
Labs & monitoringARSYNL Rx +1
53
52
FulfillmentInvyncible +2
63
65
Contract termsInvyncible +6
55
61
ARSYNL Rx · left barInvyncible · right bar

The numbers

MetricARSYNL RxInvyncible
WeighScore59.1/10061/100
GradeCC
Scorecard rank#350#303
Semaglutide$233/mo (compounded)$192/mo (0.5 mg dose, compounded)
Tirzepatide$366/mo (compounded)$210/mo (compounded)
CoverageCoverage not published40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
ARSYNL Rx

Graded #350 · C

Strengths

  • Offers compounded semaglutide and tirzepatide, including a needle-free tirzepatide hypospray option
  • Veteran-founded telehealth with clinician-prescribed, personalized treatment
  • Multi-service platform — also covers hair restoration, TRT, sexual health, and longevity
  • Medications shipped discreetly to your home

Where it loses points

  • Pricing is not shown until you select a product (product pages sit behind a bot-verification gate)
  • Compounded GLP-1s are not FDA-approved finished products
  • Compounding pharmacy partner and exact state coverage are not disclosed on the site
  • No LegitScript certification visible on the accessible pages
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard